Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 1,601–1,620 of 18,047 drug recalls

Drug Recall Terminated Historical recordClass II

Proparacaine Hydrochloride Ophthalmic Solution, USP 0.5% (sterile), 15 mL bottle, Rx only, MFG: Bausch & Lomb, NDC 24208-730-06

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
Temperature abuse: Products exposed to improper temperature above drug label specifications.
Recall initiated
September 11, 2024
Reported by FDA
October 2, 2024
Distribution
Product was distributed to two medical facilities in MD and VA.

View recall →

Drug Recall Completed Historical recordClass II

Mupirocin Ointment, USP, 2%, 22 g, Rx only, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale-Bardez, Goa 403513, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ, 07430, NDC 68462-180-22.

by Glenmark Pharmaceuticals Inc., USA

Reason
Subpotent Drug
Recall initiated
August 30, 2024
Reported by FDA
October 2, 2024
Distribution
Product was distributed nationwide within the United States.

View recall →

Drug Recall Ongoing Historical recordClass III

AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India NDC 72888-047-01

by Rubicon Research Private Limited

Reason
Discoloration
Recall initiated
August 24, 2024
Reported by FDA
September 25, 2024
Distribution
Nationwide in the US

View recall →

Drug Recall Terminated Historical recordClass III

Just Right 5000, 1.1% Sodium Fluoride, Candy Apple Flavor, Net Wt. 3.4oz (97g), Rx Only, Manufactured for Elevate Oral Care, LLC in the U.S.A with imported pump, 346 Pike Rd, Suite 5, West Palm Beach, FL 33411, NDC 57511-002-1

by Elevate Oral Care

Reason
LABELING: LABEL MIX-UP.
Recall initiated
August 20, 2024
Reported by FDA
September 18, 2024
Distribution
120 direct customers, Nationwide US. No foreign, DOD/VA.

View recall →

Drug Recall Ongoing Historical recordClass II

BARRIER THERAPY SKIN PROTECTANT CREAM (1% colloidal oatmeal), 10 FL OZ/296 ML- tube, Distributed By: Prequel, LOS ANGELES, CA 90069. UPC 8 10129 11007 4

by PREQUEL SKIN

Reason
Microbial contamination of non-sterile Products -
Recall initiated
August 28, 2024
Reported by FDA
September 18, 2024
Distribution
Distributed nationwide in USA and on line

View recall →

Drug Recall Ongoing Historical recordClass II

TIRZEPATIDE 60 mg/3mL (20/mg/mL), Rx Only, 3mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-02

by ProRx LLC

Reason
Lack of Assurance of Sterility
Recall initiated
August 22, 2024
Reported by FDA
September 11, 2024
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass II

TIRZEPATIDE 20 mg/2mL (10/mg/mL), Rx Only, 2mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-01

by ProRx LLC

Reason
Lack of Assurance of Sterility
Recall initiated
August 22, 2024
Reported by FDA
September 11, 2024
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass II

Semaglutide / Cyanocobalamin Injection: 2.5/0.5 mg/mL, 2 mL Multiple Dose Vial, Compounded Rx Product, ProRX 267-565-7008, NDC 84139-225-02

by ProRx LLC

Reason
Lack of Assurance of Sterility
Recall initiated
August 22, 2024
Reported by FDA
September 11, 2024
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass II

SEMAGLUTIDE 10mg/4mL (2.5mg/mL), 4 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd by: ProRX Exton, PA19341, NDC 84139-225-04

by ProRx LLC

Reason
Lack of Assurance of Sterility
Recall initiated
August 22, 2024
Reported by FDA
September 11, 2024
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass II

SEMAGLUTIDE 5mg/2mL (2.5mg/mL), Rx Only 2 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd by: ProRX Exton, PA19341, NDC 84139-225-01

by ProRx LLC

Reason
Lack of Assurance of Sterility
Recall initiated
August 22, 2024
Reported by FDA
September 11, 2024
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass II

Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx Product, ProRx 267-565-7008, NDC 84139-210-01

by ProRx LLC

Reason
Lack of Assurance of Sterility
Recall initiated
August 22, 2024
Reported by FDA
September 11, 2024
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass II

Semaglutide, 2 mL (2.5mg/mL), Compounded RX Product, Multidose SC inj, glass vial, ProRx, 267-565-7008, NDC 84139-225-01

by ProRx LLC

Reason
Lack of Assurance of Sterility
Recall initiated
August 22, 2024
Reported by FDA
September 11, 2024
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass I

Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL (2 units/mL), 1000 mL Sterile Single Dose Container, Rx Only, Baxter USA, NDC 0338-0433-04

by Baxter Healthcare Corporation

Reason
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Recall initiated
August 1, 2024
Reported by FDA
September 11, 2024
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Cefixime for Oral Suspension USP, 100 mg/5 mL, 50 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-405-01

by Lupin Pharmaceuticals Inc.

Reason
Subpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study.
Recall initiated
August 21, 2024
Reported by FDA
September 4, 2024
Distribution
USA nationwide.

View recall →

Drug Recall Ongoing Historical recordClass II

IBU Ibuprofen Tablets, USP, 400 mg, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, a) NDC 55111-682-01 - 100 Tablets per bottle, b) NDC 55111-682-05 - 500 Tablets per bottle.

by Dr. Reddy's Laboratories, Inc.

Reason
Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.
Recall initiated
August 6, 2024
Reported by FDA
September 4, 2024
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Ongoing Historical recordClass II

IBU Ibuprofen Tablets, USP, 600 mg, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, a)NDC 55111-683-01 - 100 Tablets per bottle, b)NDC 5511-683-05 - 500 Tablets per bottle.

by Dr. Reddy's Laboratories, Inc.

Reason
Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.
Recall initiated
August 6, 2024
Reported by FDA
September 4, 2024
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Ongoing Historical recordClass II

Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy's Laboratories, Louisiana, Shreveport, NDC 68788-9110-03.

by Preferred Pharmaceuticals, Inc.

Reason
Failed Impurities/Degradation Specifications - at 18-month Stability testing
Recall initiated
August 8, 2024
Reported by FDA
September 4, 2024
Distribution
CA and NV

View recall →

Drug Recall Ongoing Historical recordClass II

IBU Ibuprofen Tablets, USP, 800 mg, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, a)NDC 55111-684-01 - 100 Tablets per bottle, b)NDC 55111-684-05 - 500 Tablets per bottle.

by Dr. Reddy's Laboratories, Inc.

Reason
Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.
Recall initiated
August 6, 2024
Reported by FDA
September 4, 2024
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Ongoing Historical recordClass II

Indomethacin Extended-Release Capsules, USP, 75 mg, packaged in a) 60-count bottle (NDC 68462-325-60) and b) 90-count bottle (NDC 68462-325-90), Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Plot No. 2 Phase-2, Pharma Zone, SEZ, Pithampur, Dist-Dhar, Madya Pradesh - 454775, India Mfg Llc. No: 25/9/2010, Manufactured for Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430.

by Glenmark Pharmaceuticals Inc., USA

Reason
Failed Dissolution Specifications: below specification results
Recall initiated
July 31, 2024
Reported by FDA
September 4, 2024
Distribution
Nationwide USA

View recall →

Drug Recall Ongoing Historical recordClass II

Timolol Maleate Ophthalmic Solution USP, 0.5%, packaged in: a) 5mL bottle (NDC 64980-514-05), and b) 10mL bottle (NDC 64980-514-01), Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey

by FDC Limited

Reason
Defective Container: patients are unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.
Recall initiated
August 12, 2024
Reported by FDA
August 28, 2024
Distribution
Nationwide U.S.A.

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.